Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvelo Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Evelo Biosciences, Inc. Earnings Date And Information
Evelo Biosciences, Inc. last posted its earnings results on Thursday, November 9th, 2023. The company reported $-0.66 earnings per share for the quarter, topping analysts' consensus estimates of $-1.34 by $0.68. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Evelo Biosciences, Inc. has generated $-26 earnings per share over the last year ($-26.28 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Evelo Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 27th, 2025 based on prior year's report dates.
Evelo Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/09/2023 | Q3 2023 | -$1.34 | -$0.71 | 0.63 | $0 | $0 |
| 08/14/2023 | Q2 2023 | -$4.33 | -$3.78 | 0.55 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.16 | -$4.57 | -4.41 | $0 | |
| 03/16/2023 | Q4 2022 | -$6.00 | -$4.29 | 1.71 | $0 | |
| 11/14/2022 | Q3 2022 | -$6.60 | -$5.66 | 0.94 | $0 | |
| 08/11/2022 | Q2 2022 | -$11.20 | -$8.07 | 3.13 | $0 | |
| 05/12/2022 | Q1 2022 | -$11.60 | -$11.14 | 0.46 | $0 | |
| 03/24/2022 | Q4 2021 | -$12.20 | -$10.71 | 1.49 | $0 | |
| 10/28/2021 | Q3 2021 | -$11.40 | -$12.63 | -1.23 | $0 | |
| 07/29/2021 | Q2 2021 | -$10.80 | -$11.84 | -1.04 | $0 | |
| 04/29/2021 | Q1 2021 | -$10.60 | -$10.98 | -0.38 | $0 | |
| 03/09/2021 | Q4 2020 | -$9.60 | -$12.44 | -2.84 | $0 | |
| 10/30/2020 | Q3 2020 | -$9.07 | $0 | |||
| 07/31/2020 | Q2 2020 | -$12.66 | $0 | |||
| 05/11/2020 | Q1 2020 | -$14.20 | -$14.29 | -0.09 | $0 | |
| 02/14/2020 | Q4 2019 | -$14.09 | $0 | |||
| 11/05/2019 | Q3 2019 | -$13.40 | -$13.50 | -0.1 | $0 | |
| 08/06/2019 | Q2 2019 | -$13.00 | -$13.07 | -0.07 | $0 | |
| 05/03/2019 | Q1 2019 | -$12.72 | $0 | |||
| 02/15/2019 | Q4 2018 | -$9.72 | $0 |
Evelo Biosciences, Inc. Earnings: FAQ's
When is Evelo Biosciences, Inc.'s earnings date?
Evelo Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 27th, 2025 based off last year's report dates.
Did Evelo Biosciences, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Evelo Biosciences, Inc. (:EVLO) reported $-0.66 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.34 by $0.68.
How can I listen to Evelo Biosciences, Inc.'s earnings conference
call?
The conference call for Evelo Biosciences, Inc.'s latest earnings report can be listened to online.
How can I read Evelo Biosciences, Inc.'s conference call transcript?
The conference call transcript for Evelo Biosciences, Inc.'s latest earnings report can be read online.
How much profit does Evelo Biosciences, Inc. generate each year?
Evelo Biosciences, Inc. (:EVLO) has a recorded net income of $0. Evelo Biosciences, Inc. has generated $-26.28 earnings per share over the last four quarters.
What is Evelo Biosciences, Inc.'s price-to-earnings ratio?
Evelo Biosciences, Inc. (:EVLO) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.